Is BeOne Medicines AG (ONC) a Buy, Sell, or Hold?
BeOne Medicines AG
NASDAQ:ONC
$306.56 USD
$2.6 (0.86%)
- Volume
- 446.98K
- Average Volume
- 262.11K
- Market Capitalization
- $32.76B
- P/E Ratio
- 5.05
- Dividend Yield
- 0.00%
- Price Target
- $400.00
- Year High
- $385.22
- Year Low
- $253.95
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.64
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
65
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
151
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 4.57M
ONC Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ONC Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-14 | M-Exempt | 7.7 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-14 | M-Exempt | 100.04 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-14 | M-Exempt | 36.9 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-14 | S-Sale | 305.0207 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-14 | S-Sale | 306.2126 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-14 | S-Sale | 303.0687 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-14 | S-Sale | 306.9349 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-14 | S-Sale | 307.5739 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-14 | M-Exempt | 2.84 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-14 | S-Sale | 303.9264 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-10 | M-Exempt | 2.84 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-13 | M-Exempt | 2.84 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-13 | M-Exempt | 36.9 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-13 | S-Sale | 301.9364 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-13 | S-Sale | 302.7881 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-13 | S-Sale | 303.8251 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-10 | M-Exempt | 36.9 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-10 | S-Sale | 296.0672 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-10 | S-Sale | 297.2303 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-13 | S-Sale | 304.6803 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-13 | S-Sale | 305.5654 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-10 | S-Sale | 298.3516 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-10 | S-Sale | 298.9362 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-13 | S-Sale | 306.8245 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-10 | S-Sale | 300.1199 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-10 | S-Sale | 301.1828 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-10 | S-Sale | 302.1911 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-10 | S-Sale | 303.03 | 2026-07-14 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-07-13 | S-Sale | 307.405 | 2026-07-14 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-07-08 | M-Exempt | 12.23 | 2026-07-10 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-07-08 | M-Exempt | 16.41 | 2026-07-10 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-07-08 | M-Exempt | 14.96 | 2026-07-10 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-07-08 | M-Exempt | 159.03 | 2026-07-10 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-07-08 | M-Exempt | 213.32 | 2026-07-10 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-07-08 | M-Exempt | 194.47 | 2026-07-10 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-07-08 | S-Sale | 302.46 | 2026-07-10 |
| Wu Xiaobin | officer: President and COO | 2026-06-23 | S-Sale | 276.2592 | 2026-06-25 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-23 | S-Sale | 273.3049 | 2026-06-25 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-23 | S-Sale | 274.1186 | 2026-06-25 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-23 | S-Sale | 275.095 | 2026-06-25 |
| Wang Lai | officer: President, Global Head of R&D | 2026-06-23 | S-Sale | 276.735 | 2026-06-25 |
| Wu Xiaobin | officer: President and COO | 2026-06-16 | S-Sale | 266.7626 | 2026-06-18 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-16 | S-Sale | 264.8738 | 2026-06-18 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-16 | S-Sale | 265.9856 | 2026-06-18 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-16 | S-Sale | 266.6947 | 2026-06-18 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-06-16 | S-Sale | 265.975 | 2026-06-18 |
| Wang Lai | officer: President, Global Head of R&D | 2026-06-16 | S-Sale | 265.3857 | 2026-06-18 |
| Ball Titus B. | officer: Principal Accounting Officer | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Ball Titus B. | officer: Principal Accounting Officer | 2026-06-11 | S-Sale | 256.387 | 2026-06-15 |
| Ball Titus B. | officer: Principal Accounting Officer | 2026-06-11 | S-Sale | 257.53 | 2026-06-15 |
| Wang Lai | officer: President, Global Head of R&D | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Wang Lai | officer: President, Global Head of R&D | 2026-06-11 | A-Award | 20.81 | 2026-06-15 |
| Wang Lai | officer: President, Global Head of R&D | 2026-06-11 | S-Sale | 261.0021 | 2026-06-15 |
| Rosenberg Aaron | officer: Chief Financial Officer | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Rosenberg Aaron | officer: Chief Financial Officer | 2026-06-11 | A-Award | 20.81 | 2026-06-15 |
| Rosenberg Aaron | officer: Chief Financial Officer | 2026-06-11 | S-Sale | 257.7441 | 2026-06-15 |
| Wu Xiaobin | officer: President and COO | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Wu Xiaobin | officer: President and COO | 2026-06-11 | A-Award | 20.81 | 2026-06-15 |
| Wu Xiaobin | officer: President and COO | 2026-06-11 | S-Sale | 261.2017 | 2026-06-15 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-06-11 | A-Award | 20.81 | 2026-06-15 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-06-11 | S-Sale | 257.635 | 2026-06-15 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-11 | A-Award | 20.81 | 2026-06-15 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-11 | S-Sale | 256.2282 | 2026-06-15 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-11 | S-Sale | 257.5915 | 2026-06-15 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-11 | S-Sale | 258.2792 | 2026-06-15 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-11 | S-Sale | 258.81 | 2026-06-15 |
| Wang Xiaodong | director, other: Chair, Scientific Advisory Brd | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Wang Xiaodong | director, other: Chair, Scientific Advisory Brd | 2026-06-11 | A-Award | 20.81 | 2026-06-15 |
| BRANDICOURT OLIVIER | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| HOOPER ANTHONY C | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Mooney Elizabeth Fisher | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Dugan Margaret | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Sawyers Charles Lazelle | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Sharp Shalini | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Riva Alessandro | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Sawyers Charles Lazelle | director | 2026-06-11 | 0 | 2026-06-15 | |
| Sawyers Charles Lazelle | director | 2026-06-11 | 0 | 2026-06-15 | |
| Mooney Elizabeth Fisher | director: | 2026-06-11 | 0 | 2026-06-15 | |
| BAKER BROS. ADVISORS LP | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| BAKER BROS. ADVISORS LP | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Ball Titus B. | officer: Principal Accounting Officer | 2026-06-08 | S-Sale | 271.0576 | 2026-06-10 |
| Ball Titus B. | officer: Principal Accounting Officer | 2026-06-08 | S-Sale | 272.08 | 2026-06-10 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-06-08 | S-Sale | 270.2362 | 2026-06-10 |
| Lee Chan Henry | officer: SVP, General Counsel | 2026-06-08 | S-Sale | 271.2575 | 2026-06-10 |
| Wang Lai | officer: President, Global Head of R&D | 2026-06-08 | S-Sale | 269.3426 | 2026-06-10 |
| Wang Lai | officer: President, Global Head of R&D | 2026-06-08 | S-Sale | 270.73 | 2026-06-10 |
| Wu Xiaobin | officer: President and COO | 2026-06-08 | S-Sale | 269.3325 | 2026-06-10 |
| Wu Xiaobin | officer: President and COO | 2026-06-08 | S-Sale | 270.55 | 2026-06-10 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-08 | S-Sale | 270.3847 | 2026-06-10 |
| OYLER JOHN | director, officer: Chief Executive Officer | 2026-06-08 | S-Sale | 271.1411 | 2026-06-10 |
| Riva Alessandro | director | 2026-05-22 | S-Sale | 309.5142 | 2026-05-27 |
| Dugan Margaret | director | 2026-05-22 | S-Sale | 309.6017 | 2026-05-27 |
| Sanders Corazon (Corsee) D. | director | 2026-05-22 | S-Sale | 309.5896 | 2026-05-27 |
| BAKER BROS. ADVISORS LP | director | 2026-05-22 | S-Sale | 23.8512 | 2026-05-27 |
| BAKER BROS. ADVISORS LP | director | 2026-05-22 | S-Sale | 23.8512 | 2026-05-27 |
| BAKER BROS. ADVISORS LP | director | 2026-05-22 | S-Sale | 23.7905 | 2026-05-27 |
| BAKER BROS. ADVISORS LP | director | 2026-05-22 | S-Sale | 23.7905 | 2026-05-27 |
| Sharp Shalini | director | 2024-09-27 | 0 | 2026-05-15 |